Physician profile
Denis J Halmi
NPI 1710916697
$7,851.13
in general payments reported to CMS, 2019-2025
20 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,924 · 2020: $672 · 2021: $276 · 2022: $341 · 2023: $342 · 2024: $868 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $4,317.88 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $990.69 | 2019-2020 | |
| Novo Nordisk INC | $815.67 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $418.61 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Intuitive Surgical, INC. | $333.44 | 2019-2024 | |
| Teleflex LLC | $295.14 | 2023-2024 | Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Ethicon US, LLC | $212.89 | 2019-2025 | Echelon; Endopath |
| Currax Pharmaceuticals LLC | $149.75 | 2022-2025 | Contrave, Onzetra Xsail |
| Heron Therapeutics, INC. | $58.19 | 2022-2025 | Aponvie |
| Abbvie INC. | $53.82 | 2021-2024 | |
| Davol INC. | $32.43 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $31.49 | 2019 | |
| Eagle Pharmaceuticals, INC. | $24.53 | 2023 | |
| Medtronic, INC. | $21.42 | 2025 | Eea |
| Tela Bio, INC. | $20.56 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $20.04 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Merit Medical Systems INC | $16.84 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.58 | 2020 | |
| Endogastric Solutions, INC | $12.19 | 2019 | |
| Covidien LP | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denis Halmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.